HomeAboutusEditorial BoardCurrent issuearchivesSearch articlesInstructions for authorsSubscription detailsAdvertise

  Login  | Users online: 460

   Ahead of print articles    Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size  

CME Table of Contents   
Year : 2010  |  Volume : 35  |  Issue : 1  |  Page : 10-13

Concept of essential medicines and rational use in public health

1 Department of Preventive & Social Medicine, JIPMER, Puducherry-6, India
2 Specialist in Health Management, A-2/80, Janak Puri, New Delhi, India
3 Department of Pharmacy, Annamalai University, Annamalai Nagar, Tamil Nadu, India

Date of Submission09-Dec-2008
Date of Acceptance30-Oct-2009
Date of Web Publication19-Apr-2010

Correspondence Address:
Sitanshu Sekhar Kar
Department of Preventive & Social Medicine, JIPMER, Puducherry-6, Tamil Nadu
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0970-0218.62546

Rights and Permissions


How to cite this article:
Kar SS, Pradhan HS, Mohanta GP. Concept of essential medicines and rational use in public health. Indian J Community Med 2010;35:10-3

How to cite this URL:
Kar SS, Pradhan HS, Mohanta GP. Concept of essential medicines and rational use in public health. Indian J Community Med [serial online] 2010 [cited 2022 Jul 5];35:10-3. Available from: https://www.ijcm.org.in/text.asp?2010/35/1/10/62546

   Introduction Top

The Alma-Ata declaration during the International Conference on Primary Health Care in 1978 reaffirms that health is a fundamental human right and the attainment of the highest possible level of health is a most important worldwide social goal. [1] The Alma Ata declaration has outlined the eight essential components of primary health care and provision of essential medicines is one of them. [1] Medicines are integral parts of the health care and the modern health care is unthinkable without the availability of necessary medicines. They not only save lives and promote health, but prevent epidemics and diseases too. The medicines are undoubtedly one of the weapons of mankind to fight disease and illness. Accessibility to medicines is too the fundamental right of every person.

   Concept of Essential Medicines Top

World Health Organization (WHO) introduced the concept of essential medicines in 1977. [2] Essential medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford. The implementation of the concept of essential medicines is intended to be flexible and adaptable to many different situations; exactly which medicines are regarded as essential remains a national responsibility. Experience has shown that careful selection of a limited range of essential medicines results in a higher quality of care, better management of medicines (including improved quality of prescribed medicines), and a more cost-effective use of available health resources. The WHO has developed the first essential medicines list in 1977 and since then the list has been revised every 2 years. The current one is the 15 th model list released in 2007. [2] The essential medicine list contains limited cost-effective and safe medicines, while the open pharmaceutical market is flooded with large number of medicines many of which are of doubtful value. The model list of WHO serves as a guide for the development of national and institutional essential medicine list. The concept of essential medicines has been worldwide accepted as a powerful tool to promote health equity and its impact is remarkable as the essential medicines are proved to be one of the most cost-effective elements in health care.

   Selection of Essential Medicine List Top

The process by which medicines are selected is critical. An essential medicines list which is imposed from above will not reflect the need of the users or be accepted by them. It is therefore very important that the process be consultative and transparent, selection criteria be explicit, selection of the medicines be linked to evidence-based standard clinical guidelines, clinical guidelines and the list be divided into levels of care, and are regularly reviewed and updated. A review of the clinical guidelines and the list should be carried out at least every second year, and their use and the impact should be monitored. [3] The process of developing a list of essential drug list was mentioned in Box 1. [4]

   Indian Scenario Top

One of the vital components of the health care is medicine, as they account for a substantial part of household expenditure. The overall budget of medicines varies widely in different states in India. The expenditure pattern on medicines of the State Government shows that there are wide-ranging differences across states, from as little as less than 2% in Punjab to as much as 17% in Kerala during 2001-02. [5] The southern states [Additional file 1] [Additional file 2] such as Kerala and Tamil Nadu spend over 15% of their health budget on medicines. Many backward states, both in economic and health indicator terms, incurred the lowest expenditure on medicines. States such as Assam, Bihar, U.P., and Orissa spent about 5% or less of their health budget on medicines and medicines. [5] The Central Government's share of medicines in its total health budget is around 12%. In all, roughly 10% of the health budget goes into procuring medicines in India. [5] Even then, availability of medicines often is a big issue. The non-availability of required medicines jeopardizes the credibility of the public health system. Access to essential medicines is closely linked to health system performance and its utilization. The non-availability of essential medicines in the health facilities is not the only issue; there are problems of affordability and accessibility despite spending a large proportion of resources on medicines. [5] The availability of medicines is undermined by several factors: Poor medicine supply and distribution systems; insufficient health facilities and staff; and low investment in health, and the high cost of medicines. [5] The Essential Medicines List can help countries rationalize the purchasing and distribution of medicines, thereby reducing costs to the health system.

This concept of essential medicines is relatively new to India and Tamil Nadu is the first state to develop the essential medicine list as early as in 1994. Then government of Delhi too had developed its own list. The government of India and many other individual states have their own essential medicines list, and the current national list was compiled during 2003. Unfortunately, the list is not regularly up dated except for Tamil Nadu. As the list needs to be developed locally and should be based on evidence not merely on individual's experience, it is necessary first to develop clinical guidelines, called standard treatment guidelines (STG). Then based on STG the list is compiled. Delhi took the lead in developing a comprehensive Drug Policy in 1994 and was the only Indian state to have such a comprehensive policy. [6] The policy's main objective is to improve the availability and accessibility of quality essential drugs for all those in need.[6] Now many state governments too have developed STG for use within the state government health facilities. The Armed Forces Medical College (AFMC) has developed STGs for quite large number of common conditions and the treatment cost is also calculated. [7]

   Usage of Essential Medicine List Top

The concept of essential medicines has also been adopted by many international organizations, including the United Nations Children's Fund (UNICEF) and the Office of the United Nations High Commissioner for Refugees (UNHCR), as well as by non-governmental organizations and international non-profit supply agencies. Many of these organizations base their medicine supply system on the Model List. Lists of essential medicines also guide the procurement and supply of medicines in the public sector, schemes that reimburse medicine costs, medicine donations and local medicine production, and, furthermore, are widely used as information and education tools by health professionals. Health insurance schemes too are increasingly using national lists of essential medicines for reference purposes. The model list serves as a baseline for further modification (addition and deletion of new medicines), correct dosage strength, and form depending upon the national priority and available evidence. [8]

   Rational Use of Medicines Top

The selection of essential medicines is only one step towards the improvement of the quality of health care; selection needs to be followed by appropriate use. Each individual should receive the right medicine, in an adequate dose for an adequate duration, with appropriate information and follow-up treatment, and at an affordable cost. Worldwide more than 50% of all medicines are prescribed, dispensed, or sold inappropriately, while 50% of patients fail to take them correctly. Moreover, one-third of the world's population lacks access to essential medicine. [2] The situation is alarming. Unfortunately, because of inappropriate use, the effective medicines of yesterday become ineffective today. A classic example is antimicrobial medicines. Thus, in addition to achieve improved accessibility of essential medicines (availability and affordability); it is equally necessary to use the medicines appropriately, known as using rationally.

   Definition Top

The rational use of Medicines (RUM) is defined as "Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and at the lowest cost to them and their community." [9] Irrational use occurs when one or more of these conditions are not met. The use of too many medicines per patients; inappropriate use of antimicrobials, often in inadequate dosage, for non-bacterial infections; over use of injections; and prescriptions not in accordance with STG; are few common types of irrational use of medicines.

The inappropriate use of medicines is widespread. It is costly and extremely harmful both to the individual and the population as a whole mainly in childhood infection and in chronic diseases like hypertension, diabetes, epilepsy, and mental disorder. [2] Increased incidence of adverse drug events and resistance is another serious issue.

   Strategies to Promote Rational Use of Medicines Top

The following strategies have been advocated by WHO for promoting rational use of medicines. [2]

There is 3 M concept in Rational Use of Medicines (RUM): Medicines Mean Money. Thus, RUM means less profit and income for those dealing with medicines; prescribers, and sellers. This conflict of interest is particularly relevant in our country where just only 3-5% of population are covered under any form of health insurance. [10] The medical practitioners have wide scope and responsibility too in promoting rational use of medicines for better health care. Educational strategies to health care practitioners and consumers have been proved successful model for promoting RUM. One of the educational strategies is to train the medical students of different levels on RUM. The concept and usefulness of RUM need to be the part of the curriculum. A WHO manual "Guide to Good Prescribing: a Practical Manual" is a useful publication for under graduate and post graduate students is a welcome step in this endeavor. [11]

The medical practitioners need to keep themselves updated through attending seminars, conferences, and other continuing professional development programmes. These programmes should not be supported by pharmaceutical industries, as often there is conflict of interest. They should look for independent publications or drug information centres for drug-related information, but not from the medical representatives. The hospital formulary is a good source of information. The essential medicines should be the first choice during medical practice. Finally, they should take care of their clients, the patients, by spending some time with them explaining the appropriate use of prescribed medicines. The patients should be accepted as the partner in drug therapy prescribing.

   Conclusion Top

The World Medicines Situation Report 2004 of the World Health Organization (WHO) pointed out that approximately 67% of the population lives without an access to essential medicines. [12] India is reckoned among the global leaders in the manufacturing of generic medicines. However, it is also held that the largest number of populace in India is living without having an access to basic medicines. [5] For meeting the requirements of medicines at reasonable prices as also for strengthening of the indigenous manufacturing capacity and capability, the Government has, over the years, formulated policies and issued drug price control orders from time to time. Currently, National Pharmaceuticals Policy, 2005 has been drafted with key objectives of price regulation of the essential medicines, availability of good quality medicine, higher investment for increased production, emphasis on drug research and development and promoting good manufacturing practice in domestic pharmaceutical companies. [13]

Government, universities, and professional associations have a critical role to play with regard to the improvement of undergraduate, postgraduate, and continuing medical education in clinical pharmacology, therapeutics, and medicines information issues. Problem-based pharmacotherapy teaching may be an effective strategy in this endeavor. We need to change our attitude and start the process of prescription audit in government and private sector and the importance of essential drug list and RUM should be emphasized in every possible forum. The essential medicine concept is relevant to other health programs as well and results not only in better use of resources but also in better practice of medicine. It addresses several other issues such as good therapeutics and reduced side-effects of medicines, and saves money for individuals, hospitals, health care providers, and the country.

   References Top

1.Declaration of Alma Ata (1978). Available from: http://www.who.int/hpr/NPH/docs/declaration_almaata.pdf. (last accessed on 2009 Oct 10).  Back to cited text no. 1      
2.Promoting Rational Use of Medicines: Core Components. Available from: http://apps.who.int/medicinedocs/en/d/Jh3011e/2.html. (last accessed on 2009 Oct 10).  Back to cited text no. 2      
3.WHO Policy perspectives on Medicines: The selection of essential medicines. Available from: http://whqlibdoc.who.int/hq/2002/WHO_EDM_2002.2.pdf. (last accessed 2009 Oct 10).  Back to cited text no. 3      
4.The Role of Education in the Rational Use of Medicines, WHO SEARO Technical Publication Series No.45, New Delhi, 2006.  Back to cited text no. 4      
5.Sakthivel S. Access to Essential Drugs and Medicines. In: Pranay G Lal and Byword Editorial Consultants, editor. NCMH: Background papers on Financing and delivery of Health Care Services in India: New Delhi: Cirrus Graphics Private Limited; 2005. p. 185-212.  Back to cited text no. 5      
6.Chaudhury RR, Parameswar R, Gupta U, Sharma S, Tekur U, Bapna JS. Quality Medicines for the Poor: Experience of Delhi Programme on Rational Use of Drugs (1995-2000). Health Policy Plan 2005;20:124-36.  Back to cited text no. 6      
7.Standard Treatment guidelines: Medical management and Costing of selected conditions. Armed forces Medical College, Pune in collaboration with MOHFW and WHO country office, India. 2007.  Back to cited text no. 7      
8.WHO. The selection and use of essential medicines. Technical report series No. 946. Geneva: WHO press; 2007.  Back to cited text no. 8      
9.WHO Model Formulary. Geneva: WHO press; 2004.  Back to cited text no. 9      
10.Rao S. Health Insurance in India. In: Pranay G Lal and Byword Editorial Consultants, editor. NCMH: Background papers on Financing and delivery of Health Care Services in India: New Delhi: Cirrus Graphics Private Limited; 2005. p.275-95.  Back to cited text no. 10      
11.World Health Organization Teacher′s guide to good prescribing. Geneva; WHO Press; 2001.  Back to cited text no. 11      
12.World Health Organization. World Medicine Situation. Geneva: WHO press 2004.  Back to cited text no. 12      
13.National Pharmaceuticals Policy 2006. Available from: http://medind.nic.in/haa/t07/i1/haat07i1p1.pdf (last accessed on 2009 Oct 10).  Back to cited text no. 13      

This article has been cited by
1 Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
Adam Fundytus, Manju Sengar, Dorothy Lombe, Wilma Hopman, Matthew Jalink, Bishal Gyawali, Dario Trapani, Felipe Roitberg, Elisabeth G E De Vries, Lorenzo Moja, André Ilbawi, Richard Sullivan, Christopher M Booth
The Lancet Oncology. 2021; 22(10): 1367
[Pubmed] | [DOI]
2 Assessment of medicine use based on WHO drug-use indicators in public health facilities of the South Indian Union Territory
Dinesh Kumar Meena, Jayanthi Mathaiyan, Mahalakshmy Thulasingam, Kesavan Ramasamy
British Journal of Clinical Pharmacology. 2021;
[Pubmed] | [DOI]
3 Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
Mekonnen Sisay, Firehiwot Amare, Bisrat Hagos, Dumessa Edessa
Journal of Pharmaceutical Policy and Practice. 2021; 14(1)
[Pubmed] | [DOI]
4 Rational Drug Use Evaluation Based on World Health Organization Core Drug Use Indicators in Ethiopia: A Systematic Review
Birye Dessalegn Mekonnen, Mekuanent Zemene Ayalew, Asnakew Asres Tegegn
Drug, Healthcare and Patient Safety. 2021; Volume 13: 159
[Pubmed] | [DOI]
5 Availability of Key Essential Medicines in Public Health Facilities of South Indian Union Territory: One of the Crucial Components of Universal Health Coverage
Dinesh K Meena, Mathaiyan Jayanthi, Kesavan Ramasamy, Mahalakshmi T
Cureus. 2021;
[Pubmed] | [DOI]
6 Nano-Vesicle Based Anti-Fungal Formulation Shows Higher Stability, Skin Diffusion, Biosafety and Anti-Fungal Efficacy In Vitro
Isaac G. Deaguero,Md Nurul Huda,Victor Rodriguez,Jade Zicari,Taslim A. Al-Hilal,Abu Zayed Md Badruddoza,Md Nurunnabi
Pharmaceutics. 2020; 12(6): 516
[Pubmed] | [DOI]
7 Assessment of Knowledge, Attitude, and Utilization of Traditional Medicine among the Communities of Debre Tabor Town, Amhara Regional State, North Central Ethiopia: A Cross-Sectional Study
Tezera Jemere Aragaw,Dessie Tegegne Afework,Kefyalew Ayalew Getahun
Evidence-Based Complementary and Alternative Medicine. 2020; 2020: 1
[Pubmed] | [DOI]
8 Introducing health technology assessment in Tanzania
Gavin Surgey,Kalipso Chalkidou,William Reuben,Fatima Suleman,Jacqui Miot,Karen Hofman
International Journal of Technology Assessment in Health Care. 2020; 36(2): 80
[Pubmed] | [DOI]
9 Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future
Sidra Mahmood,Shahzad Hussain,Taufeeq ur Rehman,Corrado Barbui,Amanj Baker Kurdi,Brian Godman
Current Medical Research and Opinion. 2019; 35(1): 51
[Pubmed] | [DOI]
10 A re-evaluation of the framework for the protection of patents, women’s health in Nigeria and the issue of accessing pharmaceutical innovation in Africa: Designing strategies for medicines
Jennifer H. Mike
The Journal of World Intellectual Property. 2019; 22(3-4): 162
[Pubmed] | [DOI]
11 General Public Views, Attitudes, and Experiences toward Drug Safety in Dubai, United Arab Emirates: A Qualitative Approach
Doaa Alkhalidi,Shazia Qasim Jamshed,Ramadan Mohamed Elkalmi,Mirza Rafi Baig,Adeel Aslam,Mohamed Azmi Hassali
Pharmacy. 2019; 7(1): 19
[Pubmed] | [DOI]
Liliia Hala,Hanna Panfilova
EUREKA: Health Sciences. 2019; 5: 34
[Pubmed] | [DOI]
13 Drug utilization among hypertensive patients in the outpatient department of medicine in a tertiary care hospital: A cross-sectional study
Sarika G. Paradkar,Shyamal R. Sinha
Clinical and Experimental Hypertension. 2018; 40(2): 150
[Pubmed] | [DOI]
14 Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)
Emeline Moreira,Eduardo Paulino,Álvaro Henrique Ingles Garces,Mariane S. Fontes Dias,Marcos Saramago,Flora de Moraes Lino da Silva,Luiz Claudio Santos Thuler,Andréia Cristina de Melo
Medical Oncology. 2018; 35(3)
[Pubmed] | [DOI]
15 Antimalarial Drugs as Immune Modulators: New Mechanisms for Old Drugs
Jie An,Mark Minie,Tomikazu Sasaki,Joshua J. Woodward,Keith B. Elkon
Annual Review of Medicine. 2017; 68(1): 317
[Pubmed] | [DOI]
16 Essencialidade e racionalidade da relação nacional de medicamentos essenciais do Brasil
Sueli Miyuki Yamauti,José Ruben de Alcântara Bonfim,Silvio Barberato-Filho,Luciane Cruz Lopes
Ciência & Saúde Coletiva. 2017; 22(3): 975
[Pubmed] | [DOI]
17 Pharmaceutical policies: effects of policies that determine which drugs are reimbursed
Yasir Shafiq,Jan Peter Kösters,Ameer Muhammad,Rie Nakajima
Cochrane Database of Systematic Reviews. 2016;
[Pubmed] | [DOI]
18 Quantitative evaluation of essential medicines lists: the South African case study
Velisha Ann Perumal-Pillay,Fatima Suleman
BMC Health Services Research. 2016; 16(1)
[Pubmed] | [DOI]
19 Factors influencing the difference between forecasted and actual drug sales volumes under the price–volume agreement in South Korea
Sun-Young Park,Euna Han,Jini Kim,Eui-Kyung Lee
Health Policy. 2016; 120(8): 867
[Pubmed] | [DOI]
20 Access to age-appropriate essential medicines: a retrospective survey of compounding of medicines for children in hospitals in Nigeria and implications for policy development
Ebiowei Samuel F. Orubu,Chinyere Okwelogu,Olabisi Opanuga,Tony Nunn,Catherine Tuleu
Health Policy and Planning. 2016; : czw115
[Pubmed] | [DOI]
21 The “child size medicines” concept: policy provisions in Uganda
Xavier Nsabagasani,Jasper Ogwal Okeng,Anthony Mbonye,Freddie Ssengooba,Rebecca Nantanda,Herbert Muyinda,Ebba Hansen
Journal of Pharmaceutical Policy and Practice. 2015; 8(1)
[Pubmed] | [DOI]
22 Between government policy, clinical autonomy, and market demands: a qualitative study of the impact of the Prescribing Analysis System on behavior of physicians in South Korea
Dong-Sook Kim,Green Bae,Soo Yeon Yoo,Minah Kang
BMC Health Services Research. 2015; 15(1)
[Pubmed] | [DOI]
23 Opening the GATE to inclusion for people with disabilities
Chapal Khasnabis,Zafar Mirza,Malcolm MacLachlan
The Lancet. 2015; 386(10010): 2229
[Pubmed] | [DOI]
24 Investigating the Dissolution Profiles of Amoxicillin, Metronidazole, and Zidovudine Formulations used in Trinidad and Tobago, West Indies
Arlene Villarroel Stuart,Jieyu Zuo,Raimar Löbenberg
AAPS PharmSciTech. 2014; 15(5): 1060
[Pubmed] | [DOI]
25 Accessibility and use of essential medicines in health care: Current progress and challenges in India
Bansal, D. and Purohit, V.K.
Journal of Pharmacology and Pharmacotherapeutics. 2013; 4(1): 13-18
26 Comparison of essential drug list in a rural secondary care hospital in South India with Indian & world health organization list 2011
Rao, S.G. and Thomas, D. and Zachariah, S. and Kannan, M.S. and Alvarez-Uria, G.
Indian Journal of Physiology and Pharmacology. 2012; 56(4): 375-381
27 Rational drug use – As common as common sense?
V.P. Chaturvedi,A.G. Mathur,A.C. Anand
Medical Journal Armed Forces India. 2012; 68(3): 206
[Pubmed] | [DOI]


Print this article  Email this article


    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Article in PDF (365 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  

    Concept of Essen...
    Selection of Ess...
    Indian Scenario
    Usage of Essenti...
    Rational Use of ...
    Strategies to Pr...

 Article Access Statistics
    PDF Downloaded1098    
    Comments [Add]    
    Cited by others 27    

Recommend this journal

  Sitemap | What's New | Copyright and Disclaimer | Privacy Notice
  © 2007 - Indian Journal of Community Medicine | Published by Wolters Kluwer - Medknow
  Online since 15th September, 2007